Previous reports suggest that allogeneic hematopoietic stem cell transplantation (HSCT) offers a curative therapeutic option for DOCK8 deficiency [2, 12, 19–22]. Here, DOCK8 is linked to hyperinsulinemic hypoglycemia, familial, 4.